Atrion Corp
NASDAQ:ATRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Atrion Corp
Other
Atrion Corp
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Atrion Corp
NASDAQ:ATRI
|
Other
-$17k
|
CAGR 3-Years
69%
|
CAGR 5-Years
51%
|
CAGR 10-Years
22%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Other
-$5.1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-91%
|
CAGR 10-Years
N/A
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Other
-$13.1m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Other
-$20.4m
|
CAGR 3-Years
27%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-7%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Other
-$26.3m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-7%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Other
-$12.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
See Also
What is Atrion Corp's Other?
Other
-17k
USD
Based on the financial report for Jun 30, 2024, Atrion Corp's Other amounts to -17k USD.
What is Atrion Corp's Other growth rate?
Other CAGR 10Y
22%
Over the last year, the Other growth was 93%. The average annual Other growth rates for Atrion Corp have been 69% over the past three years , 51% over the past five years , and 22% over the past ten years .
